Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Organic & Biomolecular Chemistry Année : 2023

Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity

Résumé

Drug targeted delivery has become a top-priority in the world of medicine in order to develop more efficient and harmless therapeutic agents. This is important as a critical underlying problem...
Fichier non déposé

Dates et versions

hal-04235573 , version 1 (10-10-2023)

Identifiants

Citer

Isabelle Toubia, Christophe Nguyen, Stéphane Diring, Mélanie Onofre, Morgane Daurat, et al.. Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity. Organic & Biomolecular Chemistry, 2023, 21 (32), pp.6509-6523. ⟨10.1039/D3OB00565H⟩. ⟨hal-04235573⟩
14 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More